-
Start Preamble
Pursuant to § 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on June 6, 2000, Chiragene, Inc., 7 Powder Horn Drive, Warren, New Jersey 07059, made application by renewal to the Drug Enforcement Administration (DEA) for registration as a bulk manufacturer of the basic classes of controlled substances listed below:
Drug Schedule N-Ethylamphetamine (1475) I 2,5-Dimethoxyamphetamine (7396) I 3,4-Methylenedioxyamphetamine (7400) I 4-Methoxyamphetamine (7411) I Amphetamine (1100) II Methylphenidate (1724) II The firm plans to manufacture the listed controlled substances to supply their customers.
Any other such applicant and any person who is presently registered with DEA to manufacture such substances may file comments or objections to the issuance of the proposed registration.
Any such comments or objections may be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, United States Department of Justice, Washington, DC 20537, Attention: DEA Federal Register Representative (CCR), and must be filed no later than March 12, 2001.
Start SignatureDated: December 4, 2000.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.
[FR Doc. 01-747 Filed 1-9-01; 8:45 am]
BILLING CODE 4410-09-M
Document Information
- Published:
- 01/10/2001
- Department:
- Drug Enforcement Administration
- Entry Type:
- Notice
- Document Number:
- 01-747
- Pages:
- 2003-2003 (1 pages)
- PDF File:
- 01-747.pdf